Founder

Kemp Dolliver, CFA

Cherrystone Hill Research

Equity Capital Markets

We concur with <a href="https://www.smartkarma.com/profiles/673" target="_blank" data-smartkarma-citation="accounts:673">Toh Zhen Zhou</a> 's conclusion regarding the Rici Healthcare IPO (see <a href="https://www.smartkarma.com/insights/rici-healthcare-ipo-review-jack-of-all-trades-master-of-none" target="_blank" data-smartkarma-citation="insights:5835">RICI Healthcare IPO Review - Jack of All Trades, Master of None</a>) for many of the same reasons. Our primary concern is whether the bankers' forecasts (which we have not seen) adequately reflect the risks associated with the company's expansion plans.Assuming that the company completes the deal, here are the key points to monitor post-offering:<ol><li>
Ramp up of the O&amp;G and pediatric hospitals -- These three development…</li></ol>

We concur with Toh Zhen Zhou 's conclusion regarding the Rici Healthcare IPO (see RICI Healthcare IPO Review - Jack of All Trades, Master of None) for many of the same reasons. Our primary concern is whether the bankers' forecasts (which we have not seen) adequately reflect the risks associated with the company's expansion plans.Assuming that the company completes the deal, here are the key points to monitor post-offering:
Ramp up of the O&amp;G and pediatric hospitals -- These three development…

APAC IPOs & Placements

Zhen Zhou, Toh

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

RICI Healthcare (RH) plans to raise about US$145m to launch a pediatrics hospital in 2018, establish six new medical examination facilities, one multi-function facility and expand its existing Nantong Rich Hospital. The company is also expanding into Obstetrics and Gynecology (O&amp;G) by launching two specialty hospitals by the end of 2017, funded by internal resources.In this insight, we will look at:<ol><li>Each segment's growth, margins, and comparison to peers</li><li>Corporate governance issues </li><li>Evaluation of growth strategy</li><li>Valuation versus peer group</li></ol>

RICI Healthcare (RH) plans to raise about US$145m to launch a pediatrics hospital in 2018, establish six new medical examination facilities, one multi-function facility and expand its existing Nantong Rich Hospital. The company is also expanding into Obstetrics and Gynecology (O&amp;G) by launching two specialty hospitals by the end of 2017, funded by internal resources.In this insight, we will look at:Each segment's growth, margins, and comparison to peersCorporate governance issues Evaluation of growth strategyValuation versus peer group

RICI Healthcare IPO Review - Jack of All Trades, Master of None

China

Rici Healthcare Holdings Limited operates private integrate health care hospitals. The Company provides high-end medicare, specialized hospital, physical examination, medical products supply, and other related services throughout China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

RICI Healthcare (1526 HK)

Rici Lists, Then What?

We concur with Toh Zhen Zhou 's conclusion regarding the Rici Healthcare IPO (see RICI Healthcare IPO Review - Jack of All Trades, Master of...

Kemp Dolliver, CFA

RICI Healthcare IPO Review - Jack of All Trades, Master of None

RICI Healthcare (RH) plans to raise about US$145m to launch a pediatrics hospital in 2018, establish six new medical examination facilities, one...

Zhen Zhou, Toh

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)